SS
PROK icon

Steve Schonfeld’s ProKidney PROK Stock Holding History

Steve Schonfeld’s Portfolio PROK Stock Details PROK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-32,845
Closed -$58.8K – 2920
2026
Q1 		$58.8K Buy
+32,845
New +$69.7K ﹤0.01% 1948
2024
Q3 		– Sell
-11,800
Closed -$29K – 2346
2024
Q2 		$29K Buy
+11,800
New +$31.7K ﹤0.01% 1982
2022
Q3 		– Sell
-42,852
Closed -$426K – 3122
2022
Q2 		$426K Hold
42,852
– – ﹤0.01% 1451
2022
Q1 		$424K Buy
+42,852
New +$423K ﹤0.01% 1473
2021
Q4 		– Sell
-400,000
Closed -$3.92M – 2452
2021
Q3 		$3.92M Hold
400,000
– – 0.04% 506
2021
Q2 		$4.04M Buy
+400,000
New +$4.04M 0.04% 519

Other funds holding PROK

SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BL
Bleichroeder LP New York $559M AUM 83.7% 1-Year Est. Return
HWAM
Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return
AGP
Artia Global Partners Miami, Florida $542M AUM 206.64% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Steve Schonfeld's PROK Position: Q2 2026 in Review

Steve Schonfeld sold out of ProKidney (PROK) in Q2 2026, closing a stake of 32,845 shares — an estimated $58.8K sold.

Steve Schonfeld first reported a position in PROK in Q2 2021 and held it in 6 quarters. The position peaked at $4.04M in Q2 2021. 71 funds tracked by Wall St. Rank hold PROK as of Q2 2026.

  • Steve Schonfeld reported no remaining ProKidney position as of Q2 2026 after selling out during the quarter.
  • Steve Schonfeld sold 32,845 ProKidney shares in Q2 2026, an estimated $58.8K.
  • Steve Schonfeld first reported a position in ProKidney in Q2 2021 and held it in 6 quarters.
  • Steve Schonfeld's ProKidney position peaked at $4.04M in Q2 2021.
  • 71 funds tracked by Wall St. Rank held ProKidney as of Q2 2026.

Based on Schonfeld Strategic Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.